HITI
High Tide Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CA
$2.57
+1.79%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 671.6M | 594.0M | 522.3M | 487.7M | 356.9M |
| Cost of Revenue | 525.7M | 440.5M | 379.8M | 356.4M | 255.9M |
| Gross Profit | 145.9M | 153.5M | 142.5M | 131.3M | 101.0M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 124.9M | 113.8M | 101.8M | 101.2M | 90.9M |
| General & Admin Expense | 121.8M | 110.6M | 97.6M | 97.1M | 83.0M |
| Selling & Marketing Expense | 3.1M | 3.2M | 4.2M | 4.1M | 7.9M |
| Other Expenses | 24.2M | 54.2M | 35.7M | 71.5M | 82.4M |
| Total Operating Expenses | 149.1M | 168.0M | 137.5M | 172.7M | 173.3M |
| Cost and Expenses | 674.8M | 608.4M | 517.3M | 529.1M | 429.2M |
| Operating Income (EBIT) | (3.2M) | (14.4M) | 5.0M | (41.4M) | (72.3M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 15.4M | 13.4M | 12.8M | 11.6M | 9.9M |
| Net Interest Income | (15.4M) | (13.4M) | (12.8M) | (11.6M) | (9.9M) |
| Other Non-Op Income/Expense | (42.8M) | (37.0M) | (9.4M) | (7.2M) | (1.5M) |
| Non-Operating Income (excl Interest) | 26.2M | 23.6M | (3.4M) | (4.5M) | (8.5M) |
| EBT (Pre-Tax Income) | (46.0M) | (51.4M) | (4.4M) | (48.6M) | (73.8M) |
| Income Tax Expense | 226.1K | (25.0K) | (593.0K) | (7.6M) | (2.9M) |
| Bottom Line | |||||
| Net Income | (44.0M) | (50.7M) | (4.3M) | (39.3M) | (71.8M) |
| Earnings from Cont. Ops | (46.2M) | (51.4M) | (3.8M) | (41.0M) | (70.8M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (44.0M) | (50.7M) | (4.3M) | (39.3M) | (71.8M) |
| Per Share | |||||
| Basic EPS | ($0.50) | ($0.62) | ($0.05) | ($0.53) | ($1.13) |
| Diluted EPS | ($0.50) | ($0.62) | ($0.05) | ($0.53) | ($1.13) |
| Revenue Per Share | $7.64 | $7.23 | $6.57 | $6.56 | $5.68 |
| Shares | |||||
| Basic Shares Outstanding | 87.9M | 82.2M | 79.6M | 74.3M | 62.8M |
| Diluted Shares Outstanding | 87.9M | 82.2M | 79.6M | 74.3M | 62.8M |
| Profitability Metrics | |||||
| EBITDA | (2.7M) | (13.7M) | 33.8M | (4.2M) | (33.6M) |
| D&A | 26.8M | 24.3M | 25.4M | 32.8M | 30.2M |
| EBIT | (29.5M) | (38.0M) | 8.4M | (37.0M) | (63.8M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Apr 1, 2026